![]() |
Volumn 6, Issue 10, 2007, Pages 770-771
|
Steps on the road to personalized medicine
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYTOCHROME P450 2C9;
GLUCURONOSYLTRANSFERASE 1A1;
IRINOTECAN;
MERCAPTOPURINE;
WARFARIN;
AGE;
ARTICLE;
BLEEDING;
BLOOD CLOTTING DISORDER;
BODY WEIGHT;
BRAIN HEMORRHAGE;
CLINICAL PRACTICE;
COLON CANCER;
COST EFFECTIVENESS ANALYSIS;
DOSE CALCULATION;
DOSE RESPONSE;
DRUG LABELING;
DRUG MARKETING;
DRUG MEGADOSE;
DRUG MONITORING;
DRUG RESPONSE;
DRUG SAFETY;
EVIDENCE BASED MEDICINE;
FOOD AND DRUG ADMINISTRATION;
GENETIC ANALYSIS;
GENETIC VARIABILITY;
GENOTYPE ENVIRONMENT INTERACTION;
HEALTH CARE COST;
HEART INFARCTION;
INTERNATIONAL NORMALIZED RATIO;
LEUKEMIA;
PHARMACODYNAMICS;
PHARMACOGENETICS;
PRIORITY JOURNAL;
THROMBOEMBOLISM;
UNSPECIFIED SIDE EFFECT;
|
EID: 34848882252
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd2434 Document Type: Article |
Times cited : (17)
|
References (0)
|